Warren, R.; Conrad, C.; Foley, P.; Iversen, L.; Langley, R.; Kokolakis, G.; Davis, L.; Vanvoorden, V.; Wiegratz, S.; Merola, J. Bimekizumab Versus Secukinumab Continuous Maintenance of Response at Every Visit through One Year in Patients With Moderate to Severe Plaque Psoriasis: Post-Hoc Results from the BE RADIANT Phase 3b Trial. J of Skin 2022, 6, s70.